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cChylothorax is the presence of chyle in the thoracic cavitydue to a disruption of the thoracic duct. The cause of
chylothorax includes congenital malformation, trauma, neo-
plasm, and inflammation. Complications of chylothorax are
severe and include significant nutritional deficiency, immu-
nocompromised status, and metabolic derangements. These
complications are a result of the rich composition of chyle.
Chyle contains dietary fats absorbed enterally, fat-soluble vi-
tamins, protein, and T-cell lymphocytes.1 The composition
of chyle is similar to that of plasma in terms of electrolytes.
Losing a significant amount of chyle can lead to the disastrous
consequences previously listed. The diagnosis of chylothorax
is confirmed by sampling the pleural effusion with a triglyc-
eride level 110 and by the presence of chylomicrons.1,2
Management of chylothorax begins with drainage of chyle
from the pleural cavity by either tube thoracostomy or an
image-guided percutaneous drain. Medical management in-
volves diet modification through 2 modalities. The first is a
low-fat diet, rich in medium-chain fatty acids, as this will
bypass the thoracic duct via direct absorption in the portal
vein. Strict nil per os and total parenteral nutrition are the
other modalities used as bowel rest decreases the amount of
chyle flowing through the thoracic duct. Somatostatin has
been found to decrease the volume of chyle by decreasing
absorption in the gastrointestinal tract.3 This has been used
primarily in the pediatric population with sparse case reports
in the adult literature.4
Surgical management includes several therapeutic op-
tions. Surgical management is indicated for 1 L or greater of
chyle drainage over a 24-hour period or for patients who fail
to stop leaking chyle with conservative therapy. Pleurodesis,
via talc or fibrin glue, has been used with reported success.5
*Department of Cardiothoracic Surgery, Emory University School of Medi-
cine, Atlanta, Georgia.
†Section of Cardiothoracic Surgery, Emory University Hospital Midtown,
Section of Cardiothoracic Surgery, Atlanta, Georgia.
Dr. Pickens reports receiving consulting and lecture fees from Ethicon. Drs.
Ahmed and Sancheti have no commercial interests to disclose.
Address reprint requests to Allan Pickens, MD, Section of Cardiothoracic
Surgery, Emory University Hospital Midtown, 550 Peachtree St. N.E.,
Atlanta, GA 30308. E-mail: allan.pickens@emoryhealthcare.org
292 1522-2942/$-see front matter © 2012 Published by Elsevier Inc.
http://dx.doi.org/10.1053/j.optechstcvs.2012.11.003The placement of a Denver pleuroperitoneal shunt has been
used in patients who are nonoperative candidates; however,
these shunts are fraught with complications such as tender-
ness from the catheter site, obstruction, and patient noncom-
pliance.6 Thoracic duct embolization via percutaneous cath-
eterization and lymphography is another option. This
technique is successful in approximately 70% of cases in
which the thoracic duct can be cannulated.7
More definitively, the thoracic duct can be ligated, through
either isolation or mass tissue ligation, as discussed later.5,8,9
Preoperative Preparation
The key step in the ligation of the thoracic duct is the ability
to identify the duct as it emerges from the aortic hiatus.8,9
This is important in reoperative cases such as postlobectomy
and postesophagectomy chylothorax, where the planes are
obliterated and the anatomy is not well defined.1,6 To accom-
lish this, the patient is given a diet rich in fat content pre-
peratively. Several methods have been described that vary
rom a high fat diet the evening before that includes heavy
ream or ice cream.8,9 Some have advocated for enteral fat to
continue during the intraoperative period via a nasogastric
tube, nasoduodenal feeding tube, gastrostomy tube, or feed-
ing jejunostomy.8,9 This will create a high-volume flow of
hyle and allow the surgeon to identify the thoracic duct
learly.
Anatomy
The thoracic duct begins below the diaphragm at the cister-
nae chyli at the 2nd lumbar vertebrae. The duct then runs
superiorly through the aortic hiatus between the azygous
vein and the aorta. The thoracic duct then crosses themidline
at the level of the 4th to 5th thoracic vertebra and empties
into the junction of the left internal jugular and subclavian
vein, as shown in Fig. 1. There are many anatomic variations
mostly due to the embryology of the thoracic duct, which
begins as a bilateral structure. Up to 40% to 50% of the
population will have 2 or 3 major branches of the thoracic
duct; however, it is more likely to emerge as a single duct
from the aortic hiatus.1,2
Thoracoscopic thoracic duct ligation 293Figure 1 Thoracic duct anatomy. SVC  superior vena cava.
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Patient Preparation
The approach for video-assisted thoracoscopic surgery tho-
racic duct ligation is via the right chest because the descend-
ing thoracic aorta distorts the anatomy and makes exposure
of the thoracic duct on the left more difficult. A right-sided
approach also allows access to the thoracic duct before the
Figure 2 Patient positioniright and left main stem bronchus.8,9 Right-sided lung isola- tion is used and can be accomplished with a double-lumen
ndotracheal tube or a bronchial blocker. The patient is po-
itioned in the left lateral decubitus position (Fig. 2). Incision
is placed in the intercostal space one interspace below the
nframammary crease along the anterior axillary line, which
ften corresponds to the 5th intercostal space. Incision 2 is
laced approximately 1 cm inferior and 1 cm posterior to the
ip of the scapula, which usually corresponds to the 6th in-
placement of incisions.ercostal space. Incision 3 is placed along the 8th intercostal
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access site 2 and the working ports are incision/access sites 1
and 3. The authors suggest that both the surgeon and the
assistant stand on the same side, posterior to the patient.
Local anesthesia is used generously to anesthetize each
incision in the subcutaneous tissue and along the intercostal
nerves posterior to the incision. The intercostal blocks are
performed 1 interspace above and 1 interspace below the
incision. Under direct visualization, access to the right chest
is accomplished through the first incision. Digital inspection
is used to ensure there are no adhesions; adhesions can be
taken down bluntly if present. Incision 2 is made and a metal
trocar is placed using digital guidance to avoid lung paren-
chyma injury. A 5-mm30° camera is used to inspect the chest
Figure 3 Exposure of thoracic duct. IVCcavity. Using thoracoscopic guidance, incision 3 is madenearest to the diaphragm. This final port can be used to
retract the diaphragm if needed. A heavy silk stitch can be
placed superficially in the diaphragm and brought out of
incision 3 to retract the diaphragm inferiorly.
The entire right chest cavity is inspected.All fluid is evacuated
and any adhesions are taken down. The inferior pulmonary
ligament is transected down to the level of the inferior pulmo-
nary vein. The right lower lobe is then retracted superiorly and
posteriorly. The azygous vein is identified above the diaphragm
as depicted in Fig. 3. The pleura is then incised medial to the
azygous vein and a pleural flap is created anteriorly and poste-
riorly as illustrated in Fig. 4. The thoracic duct lies between the
azygous vein and the descending thoracic aorta. These 2 ana-
tomic landmarks are key, especially in reoperative cases when
rior vena cava; RLL  right lower lobe. infethe planes are obliterated (see Figs. 1 and 7).
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are identified, an attempt is made to isolate the thoracic duct.
The thoracic duct should be identified as it emerges through
the aortic hiatus. There will be less anatomic variation and
branching at this level. To confirm isolation of the thoracic
duct, it is partially transected, allowing free flow of chyle.
This confirms the correct structure has been ligated and fur-
ther emphasizes the importance of preoperative and intraop-
Figure 5 Thoracicerative enteral fat infusion to distend the thoracic duct. Chyle mshould be seen draining from the point of partial transection.
By having a high-fat-content meal immediately before the
operating room, the thoracic duct becomes distended andmore
easily identified. On confirmation of the chyle leaking from the
thoracic duct, it is ligated distally as close to the aortic hiatus as
possible and proximally about 5 cm apart with two 5-mm clips
(Figs. 5 and 6). It is best to avoid clipping the duct in multiple
ocations as the duct is friable and excessive clipping can create
igated with clip.duct lore leaks that are difficult to control.
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Thoracoscopic thoracic duct ligation 299If the thoracic duct is unable to be identified as frequently
encountered in reoperative cases (demonstrated in Fig. 7),
ass ligation is necessary to ligate the duct. The tissue
Figure 7 Exposureetween the azygous vein and the aorta is ligated justabove the diaphragm using a nonabsorbable suture. Using
a figure-of-8 stitch, the tissue between the azygous vein
and the aorta is ligated over a 2- to 3-cm area above the
-operative cases.for rediaphragm (Fig. 8).
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Thoracoscopic thoracic duct ligation 301Once the thoracic duct is ligated, there should be visual
confirmation that no further chyle is leaking. A soft straight
chest tube is placed posteriorly and apically. The tube should
be placed through the most inferior port for dependent
drainage. The chest tube can be removed once the drainage is
300 mL over 24 hours. Prior to removing the chest tube,
the patient should be fat-challenged to ensure resolution of
the chyle leak.
Postoperative Care
Postoperatively, the patient should be advanced to a diet with
high fat content to challenge the thoracic duct ligation by post-
operative day 1. The chest tube should remain until the total
drainage over a 24-hour period is300 mL and the chyle leak
has sealed. Once these conditions aremet, the chest tube can be
removed and the patient can be safely discharged home. Re-
moval of the chest tube before the chyle leak completely seals
can lead to a tension chylothorax.
Recurrence
In select cases where the initial attempt for thoracic duct
ligation is unsuccessful and the chyle leak persists postoper-
atively, several surgical options remain. The authors suggest
the following algorithm. Repeat thoracic duct ligation can be
performed with mass ligation if isolation was used in theinitial operation. Fibrin glue can also be applied liberally to
help seal the leak.1,2 If the location of the chyle leak is uncer-
ain, identification of the leak can be accomplished through
ymphography with subsequent reoperative repair depend-
ng on the location of the injury.5,7 Another option is talc
pleurodesis, which can be accomplished at the time of oper-
ation or postoperatively via chest tube infusion.1,5 Two final
pproaches include percutaneous embolization of the tho-
acic duct or laparotomy with ligation of the cisternae chyli.7
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